Adaptimmune Investors
Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Investors
%20.jpg)
Technology:
Advanced Longevity (R&D)
Number Of Exists:
Post-IPO Equity
Founded Date:
2008
Headquarters:
Oxton, York, United Kingdom
Employee Number:
51-100
Investor Type:
Healthcare Company
Industry:
Advanced and Next Generation Therapies (Various)